New blood test may help predict the onset of Huntington’s disease: Study | Health - Hindustan Times
close_game
close_game

New blood test may help predict the onset of Huntington’s disease: Study

Indo Asian News Service | By, London
Jun 09, 2017 08:49 AM IST

In a first, a blood test that can predict the onset and track progression of Huntington’s disease has been developed.

The blood test may help identify new treatments for Huntington’s disease, a genetic brain disorder, which is fatal and currently incurable. Huntington’s disease is an inherited condition in which nerve cells in the brain break down over time. The study showed that measuring the levels of neurofilament -- a protein released from damaged brain cells -- may help predict the onset of the disease as well as its progression.

Huntington’s disease is an inherited condition in which nerve cells in the brain break down over time.(Shutterstock)
Huntington’s disease is an inherited condition in which nerve cells in the brain break down over time.(Shutterstock)

“This is the first time a potential blood biomarker has been identified to track Huntington’s disease so strongly,” said Edward Wild from the University College London. The results showed that the patients who were carriers of the genetic mutation of the disease had neurofilament concentrations that were 2.6 times that of the control participants.

Hindustan Times - your fastest source for breaking news! Read now.

Further, the level rose throughout the disease course from premanifest to stage 2 disease, the researchers said. “Neurofilament has the potential to serve as a speedometer in Huntington’s disease, since a single blood test reflects how quickly the brain is changing,” Wild added.

For the study, published in the journal Lancet Neurology, the team measured neurofilament levels in blood samples from 366 volunteers who were followed for three years. In the group who had no symptoms at the start of the study, the level of neurofilament predicted subsequent disease onset, as volunteers with high neurofilament levels in the blood at the start were more likely to develop symptoms in the following three years.

Scientists are presently in the process of testing a new generation of so-called ‘gene silencing’ drugs that may put brakes on the disease. “Measuring neurofilament levels could help us figure out whether those brakes are working,” Wild noted.

Follow @htlifeandstyle for more

Oscars 2024: From Nominees to Red Carpet Glam! Get Exclusive Coverage on HT. Click Here

Catch your daily dose of Fashion, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, March 28, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On